IIM
EBS icon

INTECH Investment Management’s Emergent Biosolutions EBS Stock Holding History

INTECH Investment Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113K Sell
13,490
-6,382
-32% -$53.4K ﹤0.01% 1926
2026
Q1 		$165K Sell
19,872
-9,622
-33% -$99.7K ﹤0.01% 1798
2025
Q4 		$365K Sell
29,494
-4,493
-13% -$48.1K ﹤0.01% 1659
2025
Q3 		$300K Buy
33,987
+5,233
+18% +$40.7K ﹤0.01% 1821
2025
Q2 		$183K Buy
+28,754
New +$165K ﹤0.01% 2122

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

INTECH Investment Management's EBS Position: Q2 2026 in Review

INTECH Investment Management reduced its Emergent Biosolutions (EBS) stake by 32% in Q2 2026, selling an estimated $53.4K and leaving 13,490 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #1926.

INTECH Investment Management first reported a position in EBS in Q2 2025 and has held it in 5 quarters since. The position peaked at $365K in Q4 2025. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • INTECH Investment Management held 13,490 shares of Emergent Biosolutions worth $113K as of Q2 2026.
  • INTECH Investment Management sold 6,382 Emergent Biosolutions shares in Q2 2026, an estimated $53.4K.
  • Emergent Biosolutions made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1926 holding.
  • INTECH Investment Management first reported a position in Emergent Biosolutions in Q2 2025 and has held it in 5 quarters since.
  • INTECH Investment Management's Emergent Biosolutions position peaked at $365K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.